A Phase I study to assess PK of AZD7986 alone & with verapamil, itraconazole or diltiazem in healthy subjects

Trial Identifier: D6190C00003
Sponsor: AstraZeneca
NCTID:: NCT02653872
Start Date: January 2016
Primary Completion Date: April 2016
Study Completion Date: April 2016
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
United Kingdom London, United Kingdom